(Total Views: 741)
Posted On: 08/29/2020 11:34:40 AM
Post# of 153903
Agreed 100% TechGuru. Cancer is the indication that I value the most. I have always viewed COVID as an accelerate in the pursuit of the other indications, most notably cancer.
Sitting out in the middle of a forest with no cell service gave me some time to think about things from a different perspective. And, I had a bit of a change of mindset.
We are all currently focused on COVID (CD10, CD12) and uplisting. While these would be excellent short term catalysts if things go our way, they are still secondary to cancer.
Previously I was focused on getting an approval for COVID as the revenues and good will with the FDA would make future approvals much easier. However, even if we dont get an approval for COVID, we are making ourselves known with the FDA and our team is getting experience in this process which will still prove valuable in the future (albeit not as valuable as a revenue generating approval)
Long story short, my time horizon is not defined by years, but rather by cancer approval. I desperately want to contribute to ending the pandemic, but substantially reducing the mortality should be our primary focus.
Sitting out in the middle of a forest with no cell service gave me some time to think about things from a different perspective. And, I had a bit of a change of mindset.
We are all currently focused on COVID (CD10, CD12) and uplisting. While these would be excellent short term catalysts if things go our way, they are still secondary to cancer.
Previously I was focused on getting an approval for COVID as the revenues and good will with the FDA would make future approvals much easier. However, even if we dont get an approval for COVID, we are making ourselves known with the FDA and our team is getting experience in this process which will still prove valuable in the future (albeit not as valuable as a revenue generating approval)
Long story short, my time horizon is not defined by years, but rather by cancer approval. I desperately want to contribute to ending the pandemic, but substantially reducing the mortality should be our primary focus.
(8)
(0)
